Conferences \ BioProcessing, Biologics & Biotherapeutics Congress \ Antibody and Peptide Therapeutics \ Agenda \ Peter Wittner |
Register | Login |
Biosimilars - Will They be Worth the Effort?Thursday, 21 July 2011 at 09:30 Add to Calendar ▼2011-07-21 09:30:002011-07-21 10:30:00Europe/LondonBiosimilars - Will They be Worth the Effort? SELECTBIOenquiries@selectbiosciences.com Biosimilars have attracted interest as a way of reducing the high costs of treatment with biological products. The costs of market entry in regulated Western markets are high and market penetration has been poor so far; can companies gain the rewards they hoped for? |